Physician profile
Anne Grattan
NPI 1972945913
$1,470.96
in general payments reported to CMS, 2019-2025
20 companies · $497 in 2025
The $497 reported for 2025 was more than what 77% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $156 · 2020: $73.54 · 2021: $119 · 2022: $88.79 · 2023: $95.01 · 2024: $442 · 2025: $497.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,034.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,033.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $288.28 | 2022-2025 | Vraylar |
| Bausch & Lomb Americas INC. | $165.88 | 2024-2025 | Miebo, Xiidra, Vyzulta |
| Allergan, INC. | $149.34 | 2019-2021 | |
| Oyster Point Pharma, INC. | $130.07 | 2024-2025 | Tyrvaya |
| Tarsus Pharmaceuticals, INC. | $86.64 | 2024-2025 | Xdemvy |
| Dompe US, INC. | $78.78 | 2024-2025 | Oxervate |
| Sun Pharmaceutical Industries INC. | $78.58 | 2019-2024 | Cequa |
| Aerie Pharmaceuticals, INC. | $74.23 | 2019-2021 | |
| Harrow Eye, LLC | $64.99 | 2025 | Vevye |
| Amgen INC. | $55.85 | 2024-2025 | Tepezza |
| Shire North American Group INC | $53.81 | 2019 | |
| Alcon Vision LLC | $52.04 | 2024-2025 | Tryptyr, Rocklatan |
| Novartis Pharmaceuticals Corporation | $46.90 | 2022-2023 | |
| Rxsight INC | $25.38 | 2024 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens |
| Coopervision INC. | $23.99 | 2025 | Myday Contact Lens |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Thea Pharma INC. | $22.71 | 2023 | |
| Glaukos Corporation | $21.24 | 2019 | |
| Mallinckrodt Hospital Products INC. | $20.70 | 2024 | Acthar |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $19.58 | 2020 | |
| Eyevance Pharmaceuticals LLC | $11.97 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anne Grattan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.